Local Institution

Brampton, Ontario L6Z 4N5

0 studies enrolling now · 9 studies all time

What they study most

Atrial Fibrillation, Atrial Flutter, Diabetes Type 2, Dyslipidemia, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
• Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes — Completed
• Safety Study of BMS-770767 in Subjects With Type 2 Diabetes — Completed
• Safety Study of BMS-770767 in Subjects With Hypercholesterolemia — Completed